FOXP3 and non-small cell lung carcinoma: For instance, Foxp3+ TILs were reported to be linked to favourable clinical outcomes in non-small cell lung cancer (NSCLC) and sinonasal squamous cell carcinoma [13, 14], but others reported that Foxp3+ TILs were correlated with to worse prognosis [15, 16].